专利检索 ap:("Galectin Therapeutics Inc.") AND inv:"KLYOSOV, Anatole, A." 第 1 页

1.

发明授权
GALACTO-RHAMNOGALACTURONATE COMPOSITIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ELEVATED INDUCIBLE NITRIC OXIDE SYNTHASE 有权

公开(公告)号：EP2858651B1

公开(公告)日：2020-11-11

申请号：EP13800900.6

申请日：2013-06-06

申请人： Galectin Therapeutics Inc.

发明人： TRABER, Peter, G. , ZOMER, Eliezer , KLYOSOV, Anatole, A.

IPC分类号： A61K31/736 , A61K31/738 , A61K31/732 , A61K31/715 , A61K45/06 , A61P43/00 , A61P37/00 , A61P25/28 , A61P9/00 , A61P1/16 , A61P29/00

2.

发明公开
GALACTO-RHAMNOGALACTURONATE COMPOSITIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ELEVATED INDUCIBLE NITRIC OXIDE SYNTHASE 审中-公开
标题翻译： GALACTORHAMNOGALACTURONATZUSAMMENSETZUNGEN FOR疾病治疗具有增加诱导型一氧化氮合酶相关

公开(公告)号：EP2858651A1

公开(公告)日：2015-04-15

申请号：EP13800900.6

申请日：2013-06-06

申请人： Galectin Therapeutics Inc.

发明人： TRABER, Peter, G. , ZOMER, Eliezer , KLYOSOV, Anatole, A.

IPC分类号： A61K31/715

摘要： Aspects of the invention provide methods for treatment of a disease associated with elevated iNOS including autoimmune, chronic inflammatory, neurodegenerative, or cardiovascular diseases. In particular, aspects of the invention relate to the use of a therapeutic formulation comprising a galacto-rhamnogalacturonate for the treatment of a disease associated with elevated iNOS including autoimmune, chronic inflammatory, neurodegenerative, or cardiovascular diseases.